MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3) — Stella

Home/Gaucher Disease, Type 3/

View on ClinicalTrials.gov

Recruiting

Back to Gaucher Disease, Type 3 trials

Trial locations(1 site)

United States

University of Minnesota, Minneapolis, Minnesota

Key details

Sponsor

University of Minnesota

Enrollment target

~5 participants

Started

January 2023

Primary completion

July 2026

Age range

18 Years – 80 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.